HHS announces the launch of HealthCare.gov on Facebook

HHS announces the launch of HealthCare.gov on Facebook
HealthCare.gov on Facebook allows people to stay informed and connected about the Affordable Care Act

Health and Human Services Secretary Kathleen Sebelius today announced the launch of HealthCare.gov on Facebook: http://www.facebook.com/Healthcare.gov.

"HealthCare.gov on Facebook offers Facebook users a new tool to understand and stay informed about the Affordable Care Act," said Secretary Kathleen Sebelius. "This new page is another resource that people can use to learn about and discuss health care issues that are important to them, their family, or their small business."

HealthCare.gov on Facebook provides additional resources that allow consumers to take health care into their own hands.

HealthCare.gov on Facebook allows people to:

Search for insurance coverage using our "Insurance Finder" tool. The tool asks users to fill out two fields with basic information about themselves and the state they live in. Users are then redirected to a page on HealthCare.gov that continues with the insurance finder process based on the information provided.
Share thoughts and ideas with other members of the HealthCare.gov network.
Learn more about what the Affordable Care Act means for individuals, families, or small businesses.
Stay informed with new blog posts and webchats.
To join HealthCare.gov on Facebook visit http://www.facebook.com/Healthcare.gov, and click the "Like" button at the top of the page.



Note: All HHS press releases, fact sheets and other press materials are available at http://www.hhs.gov/news.

Last revised: September 27, 2010

Suggested Articles

AZ's tremelimumab has so far suffered a host of clinical failures. But new trial results show the company might be able to use the drug in a new way.

Roche may have just grabbed the first FDA nod for a checkpoint med in previously untreated liver cancer, but Merck is hoping it won’t be far behind.

Pfizer’s Ibrance has met with success in breast cancer since breaking onto the scene in 2015. But its first foray into early breast cancer was a bust.